Jay Foust
Head, External Engagement, Precision Diagnostics GlaxoSmithKline
Seminars
Wednesday 7th October 2026
Panel Discussion: Building the Clinical & Commercial Ecosystem for AI-Enabled Precision Pathology
12:10 pm
- How AI-enabled pathology is maturing from research into clinical deployment
- Why clinical partnerships are essential for generating evidence and accelerating adoption
- How pharma, healthcare providers and diagnostics companies can collaborate to develop scalable precision medicine solutions
- What barriers still exist to widespread implementation and how the industry can overcome them
Thursday 8th October 2026
When a Drug Program Expects Multiple Global Dx Partners: Considerations for Master CDx Agreements
9:50 am
- What are the downstream commercial considerations for a co-developing and co-labeling projects?
- How do parties manage their respective Intellectual Property portfolios when multiple global partners are likely?
- What are the baseline and optional additional commercial supplements when negotiating Master CDx Agreements?
